Innovative medical technologies have become one step closer – Press Release
[ad_1]
Ukrainians have an opportunity to participate in research carried out by start-up programs, thus they will be able to personally test the potential of modern medical approaches and technologies. Dmytro Shymkiv, the chairman of the Darnitsa Group board of directors, raised this topic in his speech at the HealthTech Talk panel discussion. This event was organized by the European Business Association with the support of the pharmaceutical company “Darnitsa”, and Philips.
Currently, Health Tech is rapidly developing – it’s a direction formed at the intersection of technology, medicine and pharmaceutics. Its main task is to make prevention and treatment of a number of diseases more accessible. As a result, patients have an opportunity to choose those instruments that will allow monitoring their health biomarkers. The use of such techniques leads to the formation of a new segment of medical services – early diagnosis of morbidity. Dmytro Shymkiv highlighted another modern trend – the use of artificial intelligence and machine learning in medicine. This will allow, along with biodata, to process information and issue recommendations based on it. Such technologies can be used in cardiology, for purposes of examining the condition of bones, monitoring pressure, etc.
When millions of people begin to monitor their health with the help of special gadgets, a huge database will get created, which can only be analyzed by artificial intelligence (AI). The possibilities of its use also in business are diverse. For example, at the moment the pharmaceutical company “Darnitsa” is working on introducing AI into business processes of different levels. Another field for applying AI is studying the behavioral models of patients and their readiness to comply with the prescriptions of doctors.
The chairman of the Darnitsa Group board of directors also stressed that the company is considering the use of artificial intelligence in the field of in silico research. Since there are currently no such platforms in the country, the company is investigating solutions available in the United States. Along with this direction, the concern also focused on research devoted to finding new ways to use existing molecules.
The Covid-19 pandemic has given impetus to the accelerated development of telemedicine. This trend is observed both at the global level, where the volume of telemedicine has grown by 35% -40%, and in Ukraine, where startups working in this direction have begun to appear. Soon, the first appointment through computer programs will become a daily routine and people will no longer go to the hospital to see a doctor. Telemedicine will help solve one of the pressing problems faced by modern medicine – a shortage of personnel.
Besides diagnostics, innovations will also affect other areas of medicine, especially surgery and long-term treatment. According to Dmytro Shymkiv, the role of medical robots will increase in these areas.
Among the significant trends, we should also mention the so-called personalized drugs, in other words, special systems that set individual dosage and trace the dynamics of drug treatment. Similar systems are tested in Ukraine currently. The direction of digiceuticals (digital therapeutics) is also promising. Within the framework of this approach, patients are prescribed not only medications and procedures, but also special mobile applications, the task of which, in particular, is to monitor and correct psychological states.
Similar tools can be used to treat patients with a diagnosis of PTSD (post-traumatic stress disorder). In particular, Dmytro Shymkiv spoke about the ways of using such applications for treatment of neuroses. We are talking about applications that monitor how a person sleeps, or through special games help a person to relax and calm down. Today, all the leaders of the pharmaceutical industry have already opened departments in their companies, whose task is to develop digiceuticals. Dmytro Shymkiv stressed that Darnitsa Group is also studying startups in this area for possible cooperation. The concern plans to offer its customers not only pills and infusions, but also applications that can be used to treat a person.
The chairman of Darnitsa Group noted that the state should provide the business with an opportunity to finance technology parks and incubators, because, in fact, this is an investment in science. At the moment, such investments can only be made from profit, which has been a source of financing for many other important areas already – culture, science, corporate and social responsibility initiatives. The experience of developed countries is indicative in this respect, in which private companies are given the opportunity to reduce the amount of taxes by means of a tax credit that is used to finance science. Unfortunately, in Ukraine there is no such incentive for investment in science yet.
Media Contact
Email: [email protected]
https://www.darnitsa.ua/en
Kyiv, Ukraine
There is no offer to sell, no solicitation of an offer to buy, and no recommendation of any security or any other product or service in this article. Moreover, nothing contained in this PR should be construed as a recommendation to buy, sell, or hold any investment or security, or to engage in any investment strategy or transaction. It is your responsibility to determine whether any investment, investment strategy, security, or related transaction is appropriate for you based on your investment objectives, financial circumstances, and risk tolerance. Consult your business advisor, attorney, or tax advisor regarding your specific business, legal, or tax situation.
Source: Story.KISSPR.com
Release ID: 94381
[ad_2]
Source link
